UK markets open in 4 hours 31 minutes

NVO Sep 2024 115.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
28.00-2.16 (-7.16%)
As of 02:35PM EDT. Market open.
Full screen
Previous close30.16
Open29.19
Bid26.85
Ask27.90
Strike115.00
Expiry date2024-09-20
Day's range28.00 - 29.19
Contract rangeN/A
Volume7
Open interest290
  • Barrons.com

    New Weight-Loss Drugs and Devices Are Coming This Week

    Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.

  • Investor's Business Daily

    Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs

    Popular weight-loss drugs have boosted Novo Nordisk and Eli Lilly. After huge gains, the drugmakers' stocks now face this risk.

  • Globe Newswire

    Novo Nordisk A/S - share repurchase programme

    Bagsværd, Denmark, 17 June 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiat